Cargando…

Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: A case study in Zambia

BACKGROUND: Pre-eclampsia and eclampsia are serious complications of pregnancy and major causes of maternal mortality and morbidity worldwide. According to systematic reviews and WHO guidelines magnesium sulphate injection (MgSO4) should be the first -line treatment for severe pre-eclampsia and ecla...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridge, Anna L, Bero, Lisa A, Hill, Suzanne R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018452/
https://www.ncbi.nlm.nih.gov/pubmed/21162717
http://dx.doi.org/10.1186/1472-6963-10-340
_version_ 1782196070913146880
author Ridge, Anna L
Bero, Lisa A
Hill, Suzanne R
author_facet Ridge, Anna L
Bero, Lisa A
Hill, Suzanne R
author_sort Ridge, Anna L
collection PubMed
description BACKGROUND: Pre-eclampsia and eclampsia are serious complications of pregnancy and major causes of maternal mortality and morbidity worldwide. According to systematic reviews and WHO guidelines magnesium sulphate injection (MgSO4) should be the first -line treatment for severe pre-eclampsia and eclampsia. Studies have shown that this safe and effective medicine is unavailable and underutilized in many resource poor countries. The objective of this study was to identify barriers to the availability and use of MgSO4 in the Zambian Public Health System. METHODS: A 'fishbone' (Ishikawa) diagram listing probable facilitators to the availability and use of MgSO4 identified from the literature was used to develop an assessment tool. Barriers to availability and use of MgSO4 were assessed at the regulatory/government, supply, procurement, distribution, health facility and health professional levels. The assessment was completed during August 2008 using archival data, and observations at a pragmatic sample of health facilities providing obstetric services in Lusaka District, Zambia. RESULTS: The major barrier to the availability of MgSO4 within the public health system in Zambia was lack of procurement by the Ministry of Health. Other barriers identified included a lack of demand by health professionals at the health centre level and a lack of in-service training in the use of MgSO4. Where there was demand by obstetricians, magnesium sulphate injection was being procured from the private sector by the hospital pharmacy despite not being registered and licensed for use for the treatment of severe pre-eclampsia and eclampsia by the national Pharmaceutical Regulatory Authority. CONCLUSIONS: The case study in Zambia highlights the complexities that underlie making essential medicines available and used appropriately. The fishbone diagram is a useful theoretical framework for illustrating the complexity of translating research findings into clinical practice. A better understanding of the supply system and of the pattern of demand for MgSO4 in Zambia should enable policy makers and stakeholders to develop and implement appropriate interventions to improve the availability and use of MgSO4.
format Text
id pubmed-3018452
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30184522011-01-11 Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: A case study in Zambia Ridge, Anna L Bero, Lisa A Hill, Suzanne R BMC Health Serv Res Research Article BACKGROUND: Pre-eclampsia and eclampsia are serious complications of pregnancy and major causes of maternal mortality and morbidity worldwide. According to systematic reviews and WHO guidelines magnesium sulphate injection (MgSO4) should be the first -line treatment for severe pre-eclampsia and eclampsia. Studies have shown that this safe and effective medicine is unavailable and underutilized in many resource poor countries. The objective of this study was to identify barriers to the availability and use of MgSO4 in the Zambian Public Health System. METHODS: A 'fishbone' (Ishikawa) diagram listing probable facilitators to the availability and use of MgSO4 identified from the literature was used to develop an assessment tool. Barriers to availability and use of MgSO4 were assessed at the regulatory/government, supply, procurement, distribution, health facility and health professional levels. The assessment was completed during August 2008 using archival data, and observations at a pragmatic sample of health facilities providing obstetric services in Lusaka District, Zambia. RESULTS: The major barrier to the availability of MgSO4 within the public health system in Zambia was lack of procurement by the Ministry of Health. Other barriers identified included a lack of demand by health professionals at the health centre level and a lack of in-service training in the use of MgSO4. Where there was demand by obstetricians, magnesium sulphate injection was being procured from the private sector by the hospital pharmacy despite not being registered and licensed for use for the treatment of severe pre-eclampsia and eclampsia by the national Pharmaceutical Regulatory Authority. CONCLUSIONS: The case study in Zambia highlights the complexities that underlie making essential medicines available and used appropriately. The fishbone diagram is a useful theoretical framework for illustrating the complexity of translating research findings into clinical practice. A better understanding of the supply system and of the pattern of demand for MgSO4 in Zambia should enable policy makers and stakeholders to develop and implement appropriate interventions to improve the availability and use of MgSO4. BioMed Central 2010-12-16 /pmc/articles/PMC3018452/ /pubmed/21162717 http://dx.doi.org/10.1186/1472-6963-10-340 Text en Copyright ©2010 Ridge et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ridge, Anna L
Bero, Lisa A
Hill, Suzanne R
Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: A case study in Zambia
title Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: A case study in Zambia
title_full Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: A case study in Zambia
title_fullStr Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: A case study in Zambia
title_full_unstemmed Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: A case study in Zambia
title_short Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: A case study in Zambia
title_sort identifying barriers to the availability and use of magnesium sulphate injection in resource poor countries: a case study in zambia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018452/
https://www.ncbi.nlm.nih.gov/pubmed/21162717
http://dx.doi.org/10.1186/1472-6963-10-340
work_keys_str_mv AT ridgeannal identifyingbarrierstotheavailabilityanduseofmagnesiumsulphateinjectioninresourcepoorcountriesacasestudyinzambia
AT berolisaa identifyingbarrierstotheavailabilityanduseofmagnesiumsulphateinjectioninresourcepoorcountriesacasestudyinzambia
AT hillsuzanner identifyingbarrierstotheavailabilityanduseofmagnesiumsulphateinjectioninresourcepoorcountriesacasestudyinzambia